Belimumab

Trade Name: 
Benlysta
Manufacturer/Distributor: 
GlaxoSmithKline
gsk.ca 1-800-387-7374
Classification: 
Immunosuppressant
ATC Class: 
L04AA26 - Belimumab
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2011/07/06
Date Marketed in Canada (yyyy/mm/dd): 
2011/10/01
Presentation: 
Injection: 120 mg/5mL. DIN: 02370050
Injection: 400 mg/5mL. DIN: 02370069
Comments: 
Treatment of systemic lupus erythematosus in adults.